Oral vaccine prevents recurring UTIs for nine years
An oral vaccine in the form of a pineapple-flavoured spray prevented recurrent urinary tract infections in 53.9 per cent of clinical trial participants
An oral vaccine in the form of a pineapple-flavoured spray prevented recurrent urinary tract infections in 53.9 per cent of clinical trial participants
Cora Sternberg discusses the significant advancement in the treatment of urothelial carcinoma, focusing on enfortumab vedotin (EV) in combination with pembrolizumab. This combination, recently approved…
“Results from these trials show that giving physicians an alert informing them of their patient’s actual risk for antibiotic resistance can help them choose the…
The 2024 AUA Annual Meeting program will offer more education and innovative programming than ever before! Join us in San Antonio.
FDA is widening its oversight of in vitro diagnostic products.
Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative…
The EAU Guidelines Panel for Muscle-invasive and Metastatic Bladder Cancer (MIBC) have prepared these guidelines to help urologists assess the evidence-based management of MIBC and…
“Ultimately, we found that in this retrospective evaluation, there was no significant difference in recurrence-free survival in those who are treated with gemcitabine and docetaxel…
Older men who are overscreened risk potential harms of overdiagnosis, such as prostate biopsy complications and a diagnosis of non-lethal prostate cancer.
If you are a medical student, you won’t want to miss the AUA2024 Medical Student Forum!
Friday, May 3, 2024 3:15 PM to 3:45 PM · 30 min. (US/Central)